Can the Gastrointestinal System alter Liver Damage Caused by COVID-19?
Keywords:
Second brain, Gut brainaxis, COVID-19 andmicrobiome, COVID-19 liver effectAbstract
Our gastrointestinal system, which is named as our second brain, is struggling with the devastating disease of recentyears, COVID-19. Thestruggle of bacteria in the intestinal microflora in terms of over coming possible liver damage causedby COVID-19 is the subject of researchers. Despite the limited number of studies, the fight againstl iver organ damage by the gastrointestinal system, which is our second brain is important.
References
I. Argou-Cardozo, F. Zeidán-Chuliá (2018) Clostridium Bacteria and Autism Spectrum Conditions: A Systematic Review and Hypothetical Contribution of Environmental Glyphosate Levels. 6(2), 29. https://doi.org/10.3390/medsci6020029
B. M. Arneth (2018) Gut-brain axis biochemical signalling from the gastrointestinal tract to the central nervous system: gut dysbiosis and altered brain function. 94(1114), 446-452. https://doi.org/10.1136/postgrad-medj-2017-135424
S. Bathina, U. N. Das (2015) Brain-derived neurotrophic factor and its clinical implications. 11(6), 1164-78. https://doi.org/10.5114/aoms.2015.56342
L. Bax, L. M. Yu, N. Ikeda, KGA Moons (2007) systematic comparison of software dedicated to meta-analysis of causal studies. 7, 40. https://doi.org/10.1186/1471-2288-7-40
Y. Belkaid, T. W. Hand (2014) Role of the microbiota in immunity and inflammation. 157(1), 121-41. https://doi.org/10.1016/j.cell.2014.03.011
D. K. Binder, H. E. Scharfman (2004) Brain-derived neurotrophic factor. 22(3), 123-31. https://doi.org/10.1080/08977190410001723308
M. I. Butler, S. Mörkl, K. V. Sandhu, J. F. Cryan, T. G. Dinan (2019) The Gut Microbiome and Mental Health: What Should We Tell Our Patients?: Le microbiote Intestinal et la Santé Mentale: que Devrions-Nous dire à nos Patients?. 64(11), 747-760. https://doi.org/10.1177/0706743719874168
M. Carabotti, A. Scirocco, M. A. Maselli, C. Severi (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. 28(2), 203-209. https://doi.org/10.1083/25830558
T. Carvalho, F. Krammer, A. Iwasaki (2021) The first 12 months of COVID-19: a timeline of immunological insights. 21(4), 245-256. https://doi.org/10.1038/s41577-021-00522-1
G. Ceccarelli, C. Borrazzo, C. Pinacchio, L. Santinelli, G. P. Innocenti, E. N. Cavallari (2021) Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study. 7, 613928. https://doi.org/10.3389/fnut.2020.613928
P. Chadalavada, V. Padbidri, R. Garg, M. Alomari, A. Babar, T. Kewan (2020) Transaminases are Potential Biomarkers of Disease Severity in COVID-19 Patients: A Single-Center Experience. 12(11), e11555. https://doi.org/10.7759/cureus.11555
S. Cheemerla, M. Balakrishnan (2021) Global Epidemiology of Chronic Liver Disease. 17(5), 365-370. https://doi.org/10.1002/cld.1061
C. Chelakkot, J. Ghim, S. H. Ryu (2018) Mechanisms regulating intestinal barrier integrity and its pathological implications. 50(8), 1-9. https://doi.org/10.1038/s12276-018-0126-x
A. Chinna Meyyappan, E. Forth, C. J. K. Wallace, R. Milev (2020) Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review. 20(1), 299. https://doi.org/10.1186/s12888-020-02654-5
N. S. Choudhary, S. Dhampalwar, N. Saraf, A. S. Soin (2021) Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. 11(6), 713-719. https://doi.org/10.1016/j.jceh.2021.05.003
M. A. Chowdhury, N. Hossain, M. A. Kashem, M. A. Shahid, A. Alam (2020) Immune response in COVID-19: A review. 13(11), 1619-1629. https://doi.org/10.1016/j.jiph.2020.07.001
M. Clapp, N. Aurora, L. Herrera, M. Bhatia, E. Wilen, S. Wakefield (2017) Gut microbiota's effect on mental health: The gut-brain axis. 7(4), 987. https://doi.org/10.4081/cp.2017.987
M. A. Conlon, A. R. Bird (2014) The impact of diet and lifestyle on gut microbiota and human health. 7(1), 17-44. https://doi.org/10.3390/nu7010017
A. L. D'Agata, J. Wu, M. K. V. Welandawe, S. V. O. Dutra, B. Kane, M. W. Groer (2019) Effects of early life NICU stress on the developing gut microbiome. 61(5), 650-660. https://doi.org/10.1002/dev.21826
G. D' Andrea (2015) Quercetin: A flavonol with multifaceted therapeutic applications?. 106, 256-71. https://doi.org/10.1016/j.fitote.2015.09.018
R. Dantzer (2018) Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa. 98(1), 477-504. https://doi.org/10.1152/physrev.00039.2016
J. R. Davie (2003) Inhibition of histone deacetylase activity by butyrate. 133(7 Suppl), 2485S-2493S. https://doi.org/10.1093/jn/133.7.2485S
C. D. Davis (2016) The Gut Microbiome and Its Role in Obesity. 51(4), 167-174. https://doi.org/10.1097/NT.0000000000000167
K. A. Dill-McFarland, Z. Z. Tang, J. H. Kemis, R. L. Kerby, G. Chen, A. Palloni (2019) Close social relationships correlate with human gut microbiota composition. 9(1), 703. https://doi.org/10.1038/s415-98-018-37298-9
A. B. Dunn, S. Jordan, B. J. Baker, N. S. Carlson (2017) The Maternal Infant Microbiome: Considerations for Labor and Birth. 42(6), 318-325. https://doi.org/10.1097/NMC.0000000000000373
Y. Farsi, A. Tahvildari, M. Arbabi, F. Vazife, L. A. Sechi, A. H. Shahidi Bonjar (2022) Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review. https://doi.org/10.3389/fcimb.2022.804644
T. C. Fung, C. A. Olson, E. Y. Hsiao (2017) Interactions between the microbiota, immune and nervous systems in health and disease. 20(2), 145-155. https://doi.org/10.1038/nn.4476
J. B. Furness, B. P. Callaghan, L. R. Rivera, H. J. Cho (2014) The enteric nervous system and gastrointestinal innervation: integrated local and central control. 39-71. https://doi.org/10.1007/978-1-4939-0897-4_3
A. Gagliardi, V. Totino, F. Cacciotti, V. Iebba, B. Neroni, G. Bonfiglio (2018) Rebuilding the Gut Microbiota Ecosystem. https://doi.org/10.3390/ijerph15081679
L. Galland (2014) The gut microbiome and the brain. 17(12), 1261-72. https://doi.org/10.1089/jmf.2014.7000
J. A. Gilbert, M. J. Blaser, J. G. Caporaso, J. K. Jansson, S. V. Lynch, R. Knight (2018) Current understanding of the human microbiome. 24(4), 392-400. https://doi.org/10.1038/nm.4517
J. E. Gold, R. A. Okyay, W. E. Licht, D. J. Hurley (2021) Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. https://doi.org/10.3390/pathogens10060763
A. Górski, R. Międzybrodzki, M. Żaczek, J. Borysowski (2020) Phages in the fight against COVID-19?. 15(10), 95-1100. https://doi.org/10.2217/fmb-2020-0082
P. Gutiérrez-Castrellón, T. Gandara-Martí, A. T. Abreu, C.D. Nieto-Rufino, E. López-Orduña, I. Jiménez-Escobar (2022) Probiotic improves symptomatic and viral clearance in COVID19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. 14(1), 2018899. https://doi.org/10.1080/19490976.2021.2018899
M.L. Hanke, T. Kielian (2011) Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. 121(9), 367-87. https://doi.org/10.1042/CS20110164
X. Jin, L. S. Lian, J. H. Hu, J. Gao, L. Zheng, Y. M. Zhang (2020) Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. 69(6), 1002-1009. https://doi.org/10.1136/gutjnl-2020-320926
S. Kaneko, M. Kurosaki, K. Nagata, R. Taki, K. Ueda, S. Hanada (2020) Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity. https://doi.org/10.1371/journal.pone.0241663
S. A. Kelly, J. Nzakizwanayo, A. M. Rodgers, L. Zhao, R. Weiser, I. A. Tekko (2021) Antibiotic Therapy and the Gut Microbiome: Investigating the Effect of Delivery Route on Gut Pathogens. 1283-1296. https://doi.org/10.1021/ac-sinfecdis.1c00081
J. Khlevner, Y. Park, K. G. Margolis (2018) Brain-Gut Axis: Clinical Implications. 727-739. https://doi.org/10.1016/j.gtc.2018.07.002
Z. Y. Kho, S. K. Lal (2018) The Human Gut Microbiome - A Potential Controller of Wellness and Disease. https://doi.org/10.3389/fmicb.2018.01835
R. Krajmalnik-Brown, Z. E. Ilhan, D. W. Kang, J. K. DiBaise (2012) Effects of gut microbes on nutrient absorption and energy regulation. 201-14. https://doi.org/10.1177/0884533611436116
J. H. Li, R. Duan, L. Li, J. D. Wood, X. Y. Wang, Y. Shu (2020) Unique characteristics of 'the second brain' - The enteric nervous system. https://doi.org/10.3389/fnagi.2021.698988
Q. Liu, W. Y. Mak, Q. Su, Y. K. Yeoh, G. C. Lui, S. S. S. Ng (2022) Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. 71(3), 544-552. https://doi.org/10.1136/gutjnl-2021-325989
T. Looft, H. K. Allen (2012) Collateral effects of antibiotics on mammalian gut microbiomes. 3(5), 463-7. https://doi.org/10.4161/gmic.21288
Y. Luo, B. Zeng, L. Zeng, X. Du, B. Li, R. Huo (2018) Gut microbiota regulates mouse behaviors through glucocorticoid receptor pathway genes in the hippocampus. (1), 187. https://doi.org/10.1038/s41398-018-0240-5
R. S. Madempudi, J. J. Ahire, J. Neelamraju, A. Tripathi, S. Nanal (2019) Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. (1), 12210. https://doi.org/10.1038/s41598-019-48554-x
A. Madison, J. K. Kiecolt-Glaser (2019) Stress, depression, diet, and the gut microbiota: human-bacteria interactions at the core of psychoneuroimmunology and nutrition. 28, 105-110. https://doi.org/10.1016/j.cobeha.2019.01.011
Y. Maeda, D. Motooka, T. Kawasaki, H. Oki, Y. Noda, Y. Adachi (2022) Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity. (1), 572. https://doi.org/10.1186/s12879-022-07358-7
V. Mallet, N. Beeker, S. Bouam, P. Sogni, S. Pol (2021) Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020. 75(4), 848-855. https://doi.org/10.1016/j.jhep.2021.04.052
A. M. Martin, E. W. Sun, G. B. Rogers, D. J. Keating (2019) The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release. 428. https://doi.org/10.3389/fphys.2019.00428
C. R. Martin, V. Osadchiy, A. Kalani, E. A. Mayer (2018) The Brain-Gut-Microbiome Axis. (2), 133-148. https://doi.org/10.1016/j.jcmgh.2018.04.003
Matijašić M., Meštrović T., Paljetak HČ, Perić M, Barešić A., Verbanac D. (2020) Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD. 21(8), 2668. https://doi.org/10.3390/ijms21082668
Morowitz M. J., Carlisle E. M., Alverdy J. C. (2011) Contributions of intestinal bacteria to nutrition and metabolism in the critically ill. 91(4), 771-85. https://doi.org/10.1016/j.suc.2011.05.001
Napolitano M., Covasa M. (2020) Microbiota Transplant in the Treatment of Obesity and Diabetes: Current and Future Perspectives. 11, 590370. https://doi.org/10.3389/fmicb.2020.590370
Newsome R. C., Gauthier J., Hernandez M. C., Abraham G.E., Robinson T.O., Williams H.B. (2021) The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. 13(1), 1-15. https://doi.org/10.1080/19490976.2021.1926840
Nobel Y. R., Phipps M., Verna E. C. (2021) COVID-19 and Effect on Liver Transplant. 19(3), 483-499. https://doi.org/10.1007/s11938-021-00355-w
Pott-Junior H., Bittencourt N. Q. P., Chacha S. F. G., Luporini R. L., Cominetti M. R., Anibal F. F. (2021) Elevations in Liver Transaminases in COVID-19: (How) Are They Related?. 8, 705247. https://doi.org/10.3389/fmed.2021.705247
Ramirez J., Guarner F., Bustos Fernandez L., Maruy A., Sdepanian V.L., Cohen H. (2020) Antibiotics as Major Disruptors of Gut Microbiota. 10, 572912. https://doi.org/10.3389/fcimb.2020.572912
Rees T., Bosch T., Douglas A. E. (2018) How the microbiome challenges our concept of self. 16(2), e2005358. https://doi.org/10.1371/journal.pbio.2005358
Rivest S. (2009) Regulation of innate immune responses in the brain. 9(6), 429-39. https://doi.org/10.1038/nri2565
Rodriguez D. M., Benninghoff A. D., Aardema N. D. J., Phatak S., Hintze K. J. (2019) Basal Diet Determined Long-Term Composition of the Gut Microbiome and Mouse Phenotype to a Greater Extent than Fecal Microbiome Transfer from Lean or Obese Human Donors. 11(7), 1630. https://doi.org/10.3390/nu11071630
V. Sasselli, V. Pachnis, A. J. Burns (2014) The enteric nervous system. 366(1), 64-73. https://doi.org/10.1016/j.ydbio.2012.01.012
B. Schnabl, D. A. Brenner (2014) Interactions between the intestinal microbiome and liver diseases. 146(6), 1513-24. https://doi.org/10.1053/j.gastro.2014.01.020
D. Schult, S. Reitmeier, P. Koyumdzhieva, T. Lahmer, M. Middelhoff, J. Erber (2022) Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19. 14(1), 2031840. https://doi.org/10.1080/19490976.2022.2031840
J. N. Sharma, A. Al-Omran, S. S. Parvathy (2007) Role of nitric oxide in inflammatory diseases. 15(6), 252-9. https://doi.org/10.1007/s10787-007-0013-x
G. Sharon, T. R. Sampson, D. H. Geschwind, S. K. Mazmanian (2016) The Central Nervous System and the Gut Microbiome. 3(4), 915-932. https://doi.org/10.1016/j.cell.2016.10.027
H. H. Shen (2015) Microbes on the mind. 28(30), 9143-5. https://doi.org/10.1073/pnas.1509590112
R. K. Singh, H. W. Chang, D. Yan, K. M. Lee, D. Ucmak, K. Wong (2017) Influence of diet on the gut microbiome and implications for human health. 15(1), 73. https://doi.org/10.1186/s12967-017-1175-y
M. Somsouk, J. D. Estes, C. Deleage, R. M. Dunham, R. Albright, J. M. Inadomi (2015) Gut epithelial barrier and systemic inflammation during chronic HIV infection. 29(1), 43-51. https://doi.org/10.1097/QAD.00000000000000511
A. Suárez-Reyes, C. A. Villegas-Valverde (2021) Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology. 23(2), 42. https://doi.org/10.37757/MR2021.V23.N2.4
K. Suganya, B. S. Koo (2020) Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. 21(20), 7551. https://doi.org/10.3390/ijms21207551
Z. Sun, Z. G. Song, C. Liu, S. Tan, S. Lin, J. Zhu (2022) Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients. 20(1), 24. https://doi.org/10.1186/s12916-021-02212-0
V. Taylor (2019) The microbiome and mental health: Hope or hype?. 44(4), 219-222. https://doi.org/10.1503/jpn.190110
R. N. Thota, S .H. Acharya, M. L. Garg (2019) Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial. 18(1), 31. https://doi.org/10.1186/s12944-019-0967-x
G. Tomasello, M. Mazzola, A. Jurjus, F. Cappello, F. Carini, P. Damiani (2017) The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping. 31(1), 245-249.
A. Vázquez-Torres, A. J. Bäumler (2016) Nitrate, nitrite and nitric oxide reductases: from the last universal common ancestor to modern bacterial pathogens. 29, 1-8. https://doi.org/10.1016/j.mib.2015.09.002
R. Vemuri, E. M. Shankar, M. Chieppa, R. Eri, K. Kavanagh (2020) Beyond Just Bacteria: Functional Biomes in the Gut Ecosystem Including Virome, Mycobiome, Archaeome and Helminths. 483. https://doi.org/10.3390/microorganisms8040483
Y. Wang, L. H. Kasper (2014) The role of microbiome in central nervous system disorders. 1-12. https://doi.org/10.1016/j.bbi.2013.12.015
J. Wasilewska, M. Klukowski (2015) Gastrointestinal symptoms and autism spectrum disorder: links and risks- a possible new overlap syndrome. 153-166. https://doi.org/10.2147/PHMT.S85717
Y. Wei, P. A. Melas, G Wegener, A. A. Mathé, C. Lavebratt (2014) Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene. 18(2). https://doi.org/10.1093/ijnp/pyu032
S. P. Wiertsema, J. van Bergenhenegouwen, J. Garssen, L. M. J. Knippels (2021) The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies. 886. https://doi.org/10.3390/nu13030886
Yeoh K. Y., Zuo T., Lui G.C., Zhang F., Liu Q. (2021) Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. 70(4), 698-706. https://doi.org/10.1136/gutjnl-2020-323020
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.
